PHILADELPHIA, PA / ACCESSWIRE / September 16, 2014 / Olfactory Biosciences Corp (OLFC) is pleased to announce that they have partnered with The Autism Asperger's Digest in a special offer for NOXO Sensory Balm(tm), a new topical medicine alternative, available online at http://noxoinfo.com/sensory Use the code "digest" and you will receive a 10% discount on NOXO.
The Autism Asperger's Digest is available now online at http://www.autismdigest.com/ or by calling 800.489.0727
What makes NOXO Sensory Balm(tm) unique? It is a simple but powerful way to tone down overwhelming perceptions! It works well for most children, teens, and adults with Autism Spectrum Disorders (ASD) by targeting sensitivities naturally, changing the person's perception to smell and other sensory inputs in a direct, safe way.
How do you use NOXO Sensory Balm(tm)? It can be applied topically under the nose. This gives a sensitive individual immediate relief from environmental odors and challenges that have the potential to trigger stress and unwanted behaviors.
How does it work? The NOXO molecules transport their messages directly to the brain's limbic system. This enables the person to cope and manage their emotional and behavioral responses to the smell and other sensory challenges they might have.
Regardless of whether a child, teen or adult has autism, sensory processing disorder or another condition, both the person and family members, teachers and other caregivers need help which NOXO Sensory Balm(tm) may provide.
NOXO Sensory Balm(tm) was developed by Olfactory Biosciences Corp using the company's own science, that of its partner Flavors and Fragrances Systems, Inc., and the science of 2004 NOBEL Prize-winners in Medicine, Richard Axel and Linda Buck. Using this science, the company has been successful in targeting specific olfactory receptors with the company's unique products resulting in the desired behavioral modifications.
For further information about NOXO Sensory Balm(tm), go to http://www.noxoinfo.com/sensory
Ingredients:A special proprietary formulation of Phytonutrients and Phytochemicals is taken from plants, flowers, roots and seeds. All ingredients are in a high quality White Petrolatum that complies with White Petrolatum USP requirements and FDA requirements ( 21 CFR 172.880) The specific chemical identities of the ingredients in this mixture are considered by us to be trade secrets and are withheld in accordance with the provisions of the 1910.1200 of the Code of Federal Regulations.
Each NOXO Sensory Balm(tm) Tin is 3 oz. (about 100 doses or applications)
**Our products are free of bee pollen, lactose, peanuts, tree nuts, shellfish, gelatin, contain all organic ingredients, and are free of allergens such as milk, wheat, gluten**
About the Autism Asperger's Digest
The Autism Asperger's Digest is a bi-monthly magazine offering the most up-to-date expertise to meet the real-life challenges, including sensory issues, behaviors, therapies, educational programs and products for those with Autism Spectrum Disorders (ASD).
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.'s NOXO division develops products targeting olfactory receptors in the nose for the desired effect. These topical alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety or help with weight control http://www.noxoinfo.com/
FORWARD-LOOKING STATEMENTS
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Contact:
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Phone: 484-278-1626
Website: http://www.noxoinfo.com/
E-mail: [email protected]
SOURCE: Olfactory Biosciences Corp